The transcription factor Forkhead box P3 (FoxP3) is expressed in glioma cells and associated with increased apoptosis

Experimental Cell Research

Volumn 319, Issue 5, 2013, Pages 731-739

  Held Feindt, Janka ^a   Hattermann, Kirsten ^b   Sebens, Susanne ^a   Krautwald, Stefan ^a   Mehdorn, H Maximilian ^a   Mentlein, Rolf ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Apoptosis; Astrocytoma; Brain tumor; Caspase; Transcription factor

Indexed keywords

CAMPTOTHECIN; CASPASE 3; CASPASE 7; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TEMOZOLOMIDE; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84873995405     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.11.018     Document Type: Article

References (30)

1. H. Katoh, P. Zheng, Y. Liu, Signalling through FOXP3 as an X-linked tumor suppressor, Int. J. Biochem. Cell Biol. 42 (2010) 1784-1787.
2. Byrne W.L., Mills K.H., Lederer J.A., O'Sullivan G.C. Targeting regulatory T cells in cancer. Cancer Res. 2011, 71:6915-6920.
3. Wang C., Lee J.H., Kim C.H. Optimal population of FoxP3 T cells in tumors requires an antigen priming-dependent trafficking receptor switch. PLoS ONE 2012, 7:e30793.
4. Hinz S., Pagerols-Raluy L., Oberg H.H., Ammerpohl O., Grüssel S., Sipos B., Grützmann R., Pilarsky C., Ungefroren H., Saeger H.D., Klöppel G., Kabelitz D., Kalthoff H. FoxP3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res. 2007, 67:8344-8350.
5. Ebert L.M., Tan B.S., Browning J., Svobodova S., Russell S.E., Kirkpatrick N., Gedye C., Moss D., Ng S.P., MacGregor D., Davis I.D., Cebon J., Chen W. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res. 2008, 68:3001-3009.
6. Karanikas V., Speletas M., Zamanakou M., Kalala F., Loules G., Kerenidi T., Barda A.K., Gourgoulianis K.I., Germenis A.E. Foxp3 expression in human cancer cells. J. Transl. Med. 2008, 6:19.
7. Wang L.H., Su L., Wang J.T. Correlation between elevated FOXP3 expression and increased lymph node metastasis of gastric cancer. Chin. Med. J. 2010, 123:3545-3549.
8. Merlo A., Casalini P., Carcangiu M.L., Malventano C., Triulzi T., Mènard S., Tagliabue E., Balsari A. FOXP3 expression and overall survival in breast cancer. J. Clin. Oncol. 2009, 27:1746-1752.
9. Tao H., Mimura Y., Aoe K., Kobayashi S., Yamamoto H., Matsuda E., Okabe K., Matsumoto T., Sugi K., Ueoka H. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Lung Cancer 2012, 75:95-101.
10. Chen G.Y., Chen C., Wang L., Chang X., Zheng P., Liu Y. Cutting edge: broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. J. Immunol. 2008, 180:5163-5166.
11. Zuo T., Wang L., Morrison C., Chang X., Zhang H., Li W., Liu Y., Wang Y., Liu X., Chan M.W., Liu J.Q., Love R., Liu C.G., Godfrey V., Shen R., Huang T.H., Yang T., Park B.K., Wang C.Y., Zheng P., Liu Y. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 2007, 129:1275-1286.
12. Niu J., Jiang C., Li C., Liu L., Li K., Jian Z., Gao T. Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction. Cancer Immunol. Immunother. 2011, 60:1109-1118.
13. Zhang H.Y., Sun H. Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer. Cancer Lett. 2010, 287:91-97.
14. Zuo T., Liu R., Zhang H., Chang X., Liu Y., Wang L., Zheng P., Liu Y. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J. Clin. Invest. 2007, 117:3765-3773.
15. Wang L., Liu R., Li W., Chen C., Katoh H., Chen G.Y., McNally B., Lin L., Zhou P., Zuo T., Cooney K.A., Liu Y., Zheng P. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell 2009, 16:336-346.
16. Liu R., Wang L., Chen G., Katoh H., Chen C., Liu Y., Zheng P. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Res. 2009, 69:2252-2259.
17. McInnes N., Sadlon T.J., Brown C.Y., Pederson S., Beyer M., Schultze J.L., McColl S., Goodall G.J., Barry S.C. FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells. Oncogene 2012, 31:1045-1054.
18. Magg T., Mannert J., Ellwart J.W., Schmid I., Albert M.H. Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells. Eur. J. Immunol. 2012, 42:1627-1638.
19. Louis D.N. Molecular pathology of malignant gliomas. Annu. Rev. Pathol. 2006, 1:97-117.
20. Mentlein R., Hattermann K., Held-Feindt J. Lost in disruption: Role of proteases in glioma invasion and progression. Biochim. Biophys. Acta 2012, 1825:178-185.
21. Waziri A. Glioblastoma-derived mechanisms of systemic immunosuppression. Neurosurg. Clin. North Am. 2010, 21:31-42.
22. Wei J., Barr J., Kong L.Y., Wang Y., Wu A., Sharma A.K., Gumin J., Henry V., Colman H., Sawaya R., Lang F.F., Heimberger A.B. Glioma-associated cancer-initiating cells induce immunosuppression. Clin. Cancer Res. 2010, 16:461-473.
23. Mentlein R., Held-Feindt J. Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. J. Neurochem. 2002, 83:747-753.
24. Ludwig A., Schulte A., Schnack C., Hundhausen C., Reiss K., Brodway N., Held-Feindt J., Mentlein R. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. J. Neurochem. 2005, 93:1293-1303.
25. Hattermann K., Held-Feindt J., Lucius R., Sebens Müerköster S., Penfold M.E., Schall T.J., Mentlein R. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates anti-apoptotic effects. Cancer Res. 2010, 70:3299-3308.
26. Sebens Müerköster S., Werbing V., Sipos B., Debus M.A., Witt M., Großmann M., Leisner D., Kötteritzsch J., Kappes H., Klöppel G., Altevogt P., Fölsch U.R., Schäfer H. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 2007, 26:2759-2768.
27. Lal G., Bromberg J.S. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009, 114:3727-3735.
28. Jung D.J., Jin D.H., Hong S.W., Kim J.E., Shin J.S., Kim D., Cho B.J., Hwang Y.I., Kang J.S., Lee W.J. Foxp3 expression in p53-dependent DNA damage responses. J. Biol. Chem. 2010, 285:7995-8002.
29. Li W., Wang L., Katoh H., Liu R., Zheng P., Liu Y. Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers. Cancer Res. 2011, 71:2162-2171.
30. Frattini V., Pisati F., Speranza M.C., Poliani P.L., Frigé G., Cantini G., Kapetis D., Cominelli M., Rossi A., Finocchiaro G., Pellegatta S. FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration. Oncotarget 2012, 3:1146-1157.